当前位置: X-MOL 学术Cell Tissue Bank. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment
Cell and Tissue Banking ( IF 1.5 ) Pub Date : 2021-01-04 , DOI: 10.1007/s10561-020-09896-3
Saeid Bagheri-Mohammadi 1, 2, 3
Affiliation  

Alzheimer's disease (AD) is a neuronal disorder with insidious onset and slow progression, leading to growing global concern with huge implications for individuals and society. The occurrence of AD has been increased and has become an important health issue throughout the world. In recent years, the care of more than 35 million patients with AD costs over $ 600 billion per year, it is approximately 1 percent of the global Gross Domestic Product. Currently, the therapeutic approach is not effective for neurological deficits especially after the development of these major neurological disorders. The discovery of the technique called cell-based therapy has shown promising results and made important conclusions beyond AD using the stem cells approach. Here we review recent progress on stem cell-based therapy in the context of AD.



中文翻译:

基于干细胞的疗法作为阿尔茨海默病的一种有前途的方法:目前对新疗法的看法

阿尔茨海默病 (AD) 是一种起病隐匿、进展缓慢的神经元疾病,引起全球日益关注,对个人和社会产生巨大影响。AD的发生率有所增加,并已成为全世界重要的健康问题。近年来,每年治疗超过 3500 万名 AD 患者的费用超过 6000 亿美元,约占全球国内生产总值的 1%。目前,该治疗方法对神经功能缺损无效,尤其是在这些主要神经系统疾病发展之后。被称为基于细胞的疗法的技术的发现显示出有希望的结果,并使用干细胞方法得出了超越 AD 的重要结论。在这里,我们回顾了 AD 背景下基于干细胞的治疗的最新进展。

更新日期:2021-01-05
down
wechat
bug